Clincosm LogoSign in Get a demo

recurrent melanoma

Showing 51 - 75 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma, Stage IIIc Melanoma, Stage IV Melanoma Trial in Nashville (other, procedure, genetic)

Terminated
Has Results
  • Recurrent Melanoma
  • +2 more
  • laboratory biomarker identification and analysis
  • +4 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 21, 2016

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Cincinnati, Columbus (Recombinant Interferon Alfa, Bevacizumab)

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • Recombinant Interferon Alfa
  • Bevacizumab
  • Cincinnati, Ohio
  • +1 more
Feb 18, 2016

Mucosal Melanoma, Recurrent Melanoma, Stage IIIA Skin Melanoma Trial in Australia, United States (Carboplatin, Laboratory

Completed
Has Results
  • Mucosal Melanoma
  • +5 more
  • Birmingham, Alabama
  • +218 more
Sep 28, 2015

Stage IV Melanoma, Recurrent Melanoma Trial in Cleveland (recombinant interferon beta)

Completed
  • Stage IV Melanoma
  • Recurrent Melanoma
  • recombinant interferon beta
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Oct 1, 2015

Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in New York (Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 16, 2015

Basal Cell Carcinoma of the Skin, Eccrine Carcinoma of the Skin, Recurrent Adult Soft Tissue Sarcoma Trial in Bronx (isolated

Withdrawn
  • Basal Cell Carcinoma of the Skin
  • +10 more
  • isolated limb perfusion
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jul 22, 2015

Stage IV Melanoma, Recurrent Melanoma Trial run by the NHLBI (allogeneic lymphocytes, anti-thymocyte globulin, cyclophosphamide)

Terminated
  • Stage IV Melanoma
  • Recurrent Melanoma
  • allogeneic lymphocytes
  • +3 more
  • Bethesda, Maryland
    National Heart, Lung, and Blood Institute
Apr 27, 2015

Recurrent Melanoma, Stage IV Melanoma Trial in Sacramento (7-hydroxystaurosporine, laboratory biomarker analysis,

Terminated
Has Results
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Sacramento, California
    UC Davis Cancer Center
Feb 17, 2015

Recurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma Trial in Portland (gp100:209-217(210M) Peptide Vaccine, HPV

Completed
  • Recurrent Melanoma
  • +9 more
  • gp100:209-217(210M) Peptide Vaccine
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jan 23, 2015

Acral Lentiginous Malignant Melanoma, Recurrent Melanoma, Stage IIIA Melanoma Trial in United States (imatinib mesylate,

Completed
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +5 more
  • imatinib mesylate
  • laboratory biomarker analysis
  • Los Angeles, California
  • +7 more
Dec 15, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Atlanta, Boston, Richmond (cabozantinib-s-malate,

Terminated
  • Recurrent Melanoma
  • +5 more
  • Atlanta, Georgia
  • +2 more
Sep 23, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • Akt inhibitor MK2206
  • +2 more
  • Atlanta, Georgia
  • +3 more
May 16, 2014

Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (recombinant fowlpox-TRICOM vaccine, laboratory biomarker analysis)

Terminated
  • Recurrent Melanoma
  • Stage IV Melanoma
  • recombinant fowlpox-TRICOM vaccine
  • laboratory biomarker analysis
  • Chicago, Illinois
    University of Chicago
Jun 6, 2014

Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Chicago (saracatinib)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 6, 2014

Recurrent Melanoma, Stage IV Melanoma Trial in United States (sorafenib tosylate, tipifarnib, temsirolimus)

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Melanoma
  • sorafenib tosylate
  • +2 more
  • Little Rock, Arkansas
  • +172 more
May 2, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in New Haven, Minneapolis (dasatinib)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • New Haven, Connecticut
  • +1 more
Apr 29, 2014

Mucosal Melanoma, Recurrent Melanoma, Stage IV Melanoma Trial in Tampa (temsirolimus, selumetinib, laboratory biomarker

Terminated
Has Results
  • Mucosal Melanoma
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 29, 2014

Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (wild-type reovirus)

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Melanoma
  • wild-type reovirus
  • Rochester, Minnesota
    Mayo Clinic
Mar 21, 2014

Recurrent Melanoma, Stage IV Melanoma Trial in Seattle (drug, biological, other, genetic)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2014

Melanoma, Recurrent Melanoma, Stage III Melanoma Trial in Houston (sorafenib tosylate, temsirolimus)

Completed
  • Melanoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 9, 2014

Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (drug, biological, other)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Oct 25, 2013

Recurrent Melanoma, Stage III Melanoma Trial in Durham (drug, biological, other)

Completed
  • Recurrent Melanoma
  • Stage III Melanoma
  • isolated limb perfusion
  • +4 more
  • Durham, North Carolina
    American College of Surgeons Oncology Group
Jul 15, 2013

Stage IV Melanoma, Recurrent Melanoma Trial run by the NCI (gp100 antigen, interleukin-2)

Completed
  • Stage IV Melanoma
  • Recurrent Melanoma
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial (dendritic cell-gp100-MART-1 antigen vaccine, sargramostim)

Completed
  • Stage IV Melanoma
  • +2 more
  • (no location specified)
Jun 19, 2013

Stage IV Melanoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial run by the NCI (flt3 ligand, gp100 antigen,

Completed
  • Stage IV Melanoma
  • +3 more
  • flt3 ligand
  • +4 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013